A prospective comparative study on two different radiotherapy delivery technique in the treatment of left sided breast cancer
Phase 3
Completed
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2023/07/054694
- Lead Sponsor
- Anjan Bera
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Age 20 -70 years
ECOG performance status 0-2
Histologically confirmed left-sided breast carcinomas
Post Operative Stages I, II, and III
Adequate bone marrow function
Adequate hepatic and renal function
Participants can understand the study and sign informed consent for the study.
Exclusion Criteria
Right sided breast carcinomas
ECOG >2
Previous history of any radiotherapy
Distal metastatic disease (Stage IV)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The difference in dosimetric data & acute toxicity in patients of leftsided breast cancers treated by 3DCRT Technique with DIBH & by Free Breathing IMRT. <br/ ><br> <br/ ><br>Timepoint: 2 yrs <br/ ><br>
- Secondary Outcome Measures
Name Time Method The difference in acute toxicities of breast cancers treated by 3DCRT Technique with DIBH & by Free Breathing IMRT. <br/ ><br>Timepoint: 2 yrs
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does deep inspiration breath hold technique reduce cardiac toxicity in left-sided breast cancer radiotherapy?
What are the comparative lung toxicity profiles of 3D conformal DIBH vs free breathing IMRT in breast cancer?
Which anatomical biomarkers predict optimal response to DIBH-based 3D conformal radiotherapy in left-sided breast cancer?
What are the dosimetric advantages of IMRT over 3D conformal radiotherapy in left-sided breast cancer treatment?
How does phase III trial CTRI/2023/07/054694 compare with standard radiotherapy protocols for breast cancer?